Transcatheter arterial chemoembolization combined with radiofrequency ablation delays tumor progression and prolongs overall survival in patients with intermediate (BCLC B) hepatocellular carcinoma.

BMC Cancer · 2014 · PMC4256894 · PMID 25409554

Europe PMC DOI

hedged sentence

0.5100

closest p · 10.2× alpha

0.5100

boldest claim

The sentences

did not reach statistical significanceP = 0.51not close (p > 0.1)

26/35, 74.3%), the difference did not reach statistical significance (P = 0.51).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.